https://timesofindia.indiatimes.com/india/amid-efficacy-row-covaxin-gets-thumbs-up-from-lancet/articleshow/80413712.cms
HYDERABAD: Amid a raging controversy over the efficacy of Covaxin, India’s first indigenous Covid-19 vaccine, reputed medical journal the Lancet Infectious Diseases on Friday...